{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:40:01Z","timestamp":1782337201028,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Ultrasound"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Progressive cardiac fibrosis is the central aspect of the myocardial involvement in systemic sclerosis (SSc). We hypothesized that circulating biomarkers of the cardiac fibrosis may be useful in the early diagnosis of the cardiac manifestation in this disease. Thus, we investigated the potential correlations between the levels of galectin-3, soluble suppression of tumorigenicity-2 (sST2) and the echocardiographic markers of the myocardial mechanics in SSc patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty patients (57.3\u2009\u00b1\u200913.7\u2009years, 36 female) were investigated. In addition to the conventional echocardiography, tissue Doppler and speckle tracking-derived strain techniques were used to assess the function of both ventricles and atria. To estimate the correlations between galectin-3 and sST2 levels and the echocardiographic variables, partial correlation method was used with age as correcting factor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In age adjusted analysis galectin-3 level showed significant correlation with left ventricular global longitudinal strain (r\u2009=\u20090.460,<jats:italic>p<\/jats:italic>\u2009=\u20090.005); grade of left ventricular diastolic dysfunction (r\u2009=\u20090.394,<jats:italic>p<\/jats:italic>\u2009=\u20090.013); septal e\u2019 (r\u2009=\u2009\u2212\u20090.369,<jats:italic>p<\/jats:italic>\u2009=\u20090.021); septal E\/e\u2019 (r\u2009=\u20090.380,<jats:italic>p<\/jats:italic>\u2009=\u20090.017) and with the grade of mitral regurgitation (r\u2009=\u20090.323,<jats:italic>p<\/jats:italic>\u2009=\u20090.048). No significant correlation was found between sST2 levels and the echocardiographic variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Galectin-3 levels, but not sST2 levels show significant correlation with the parameters of the left ventricular systolic and diastolic function. Galectin-3 may be a useful biomarker for the screening and early diagnosis of SSc patients with cardiac involvement.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12947-022-00272-7","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T12:02:56Z","timestamp":1642507376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Galectin-3 and sST2: associations to the echocardiographic markers of the myocardial mechanics in systemic sclerosis \u2013 a pilot study"],"prefix":"10.1186","volume":"20","author":[{"given":"Vivien","family":"V\u00e9rtes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9l","family":"Porp\u00e1czy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"N\u00f3gr\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"T\u0151k\u00e9s-F\u00fczesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Hajdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Czirj\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Kom\u00f3csi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8812-7000","authenticated-orcid":false,"given":"R\u00e9ka","family":"Faludi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"19","key":"272_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989\u20132003.","journal-title":"N Engl J Med"},{"issue":"4","key":"272_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/rheumatology\/keq402","volume":"50","author":"T Pint\u00e9r","year":"2011","unstructured":"Pint\u00e9r T, Faludi R, Magyari B, Vorobcsuk A, Kumanovics G, Minier T, et al. Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies. Rheumatology (Oxford). 2011;50(4):781\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"272_CR3","first-page":"iii45","volume":"48 Suppl 3","author":"A Kahan","year":"2009","unstructured":"Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii45\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Suppl 71","key":"272_CR4","first-page":"S30","volume":"30","author":"M Hinchcliff","year":"2012","unstructured":"Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30(2 Suppl 71):S30\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"272_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.semarthrit.2014.04.001","volume":"44","author":"R Faludi","year":"2014","unstructured":"Faludi R, K\u00f6lt\u0151 G, Bartos B, Csima G, Czirj\u00e1k L, Kom\u00f3csi A. Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: determinants of mortality and disease progression. Semin Arthritis Rheum. 2014;44(2):220\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"15","key":"272_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","volume":"72","author":"AH Tenn\u00f8e","year":"2018","unstructured":"Tenn\u00f8e AH, Murbr\u00e6ch K, Andreassen JC, Fretheim H, Garen T, Gude E, et al. Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis. J Am Coll Cardiol. 2018;72(15):1804\u201313.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"272_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ard.2008.103382","volume":"69","author":"Y Allanore","year":"2010","unstructured":"Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR scleroderma trial and research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010;69(1):218\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"272_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ehjci\/jes047","volume":"13","author":"S Spethmann","year":"2012","unstructured":"Spethmann S, Dreger H, Schattke S, Riemekasten G, Borges AC, Baumann G, et al. Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvement. Eur Heart J Cardiovasc Imaging. 2012;13(10):863\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"272_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/acr2.1037","volume":"1","author":"AH Tenn\u00f8e","year":"2019","unstructured":"Tenn\u00f8e AH, Murbr\u00e6ch K, Andreassen JC, Fretheim H, Midtvedt \u00d8, Garen T, et al. Systolic dysfunction in systemic sclerosis: prevalence and prognostic implications. ACR Open Rheumatol. 2019;1(4):258\u201366.","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"272_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00059-014-4113-2","volume":"40","author":"E Durmus","year":"2015","unstructured":"Durmus E, Sunbul M, Tigen K, Kivrak T, Ozen G, Sari I, et al. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study. Herz. 2015;40(4):709\u201315.","journal-title":"Herz."},{"key":"272_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003792","volume":"9","author":"M Mukherjee","year":"2016","unstructured":"Mukherjee M, Chung SE, Ton VK, Tedford RJ, Hummers LK, Wigley FM, et al. Unique abnormalities in right ventricular longitudinal strain in systemic sclerosis patients. Circ Cardiovasc Imaging. 2016;9:e003792.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"272_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1378\/chest.128.2.755","volume":"128","author":"P Lindqvist","year":"2005","unstructured":"Lindqvist P, Caidahl K, Neuman-Andersen G, Ozolins C, Rantap\u00e4\u00e4-Dahlqvist S, Waldenstr\u00f6m A, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest. 2005;128(2):755\u201363.","journal-title":"Chest."},{"key":"272_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1476-7120-12-30","volume":"12","author":"G \u00c1goston","year":"2014","unstructured":"\u00c1goston G, Gargani L, Miglioranza MH, Caputo M, Badano LP, Moreo A, et al. Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. Cardiovasc Ultrasound. 2014;12:30.","journal-title":"Cardiovasc Ultrasound"},{"issue":"4","key":"272_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cardfail.2018.02.012","volume":"24","author":"A Porp\u00e1czy","year":"2018","unstructured":"Porp\u00e1czy A, N\u00f3gr\u00e1di \u00c1, Kehl D, Strenner M, Minier T, Czirj\u00e1k L, et al. Impairment of left atrial mechanics is an early sign of myocardial involvement in systemic sclerosis. J Card Fail. 2018;24(4):234\u201342.","journal-title":"J Card Fail"},{"issue":"7","key":"272_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.amjcard.2018.06.021","volume":"122","author":"\u00c1 N\u00f3gr\u00e1di","year":"2018","unstructured":"N\u00f3gr\u00e1di \u00c1, Porp\u00e1czy A, Porcsa L, Minier T, Czirj\u00e1k L, Kom\u00f3csi A, et al. Relation of right atrial mechanics to functional capacity in patients with systemic sclerosis. Am J Cardiol. 2018;122(7):1249\u201354.","journal-title":"Am J Cardiol"},{"issue":"6","key":"272_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/rheumatology\/ker357","volume":"51","author":"A Kom\u00f3csi","year":"2012","unstructured":"Kom\u00f3csi A, Vorobcsuk A, Faludi R, Pint\u00e9r T, Lenkey Z, K\u00f6lt\u0151 G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford). 2012;51(6):1027\u201336.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"272_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10067-013-2358-4","volume":"33","author":"G K\u00f6lt\u0151","year":"2014","unstructured":"K\u00f6lt\u0151 G, Faludi R, Aradi D, Bartos B, Kum\u00e1novics G, Minier T, et al. Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort. Clin Rheumatol. 2014;33(2):197\u2013205.","journal-title":"Clin Rheumatol"},{"issue":"6 Suppl 86","key":"272_CR18","first-page":"S-75","volume":"32","author":"G K\u00f6lt\u0151","year":"2014","unstructured":"K\u00f6lt\u0151 G, Vuolteenaho O, Szokodi I, Faludi R, Tornyos A, Ruskoaho H, et al. Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-75\u201381.","journal-title":"Clin Exp Rheumatol"},{"key":"272_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijcard.2016.08.246","volume":"223","author":"Y Allanore","year":"2016","unstructured":"Allanore Y, Kom\u00f3csi A, Vettori S, Hachulla E, Hunzelmann N, Distler J, et al. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis. Int J Cardiol. 2016;223:385\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"272_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.114.218370","volume":"351","author":"LC Li","year":"2014","unstructured":"Li LC, Li J, Gao J. Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther. 2014;351(2):336\u201343.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"272_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/1354750X.2019.1642959","volume":"24","author":"AJ Rieth","year":"2019","unstructured":"Rieth AJ, Jung C, Gall H, Rolf A, Mitrovic V, Hamm CW, et al. Association of galectin-3 with changes in left ventricular function in recent-onset dilated cardiomyopathy. Biomarkers. 2019;24(7):652\u20138.","journal-title":"Biomarkers."},{"issue":"3","key":"272_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1440-1681.13048","volume":"46","author":"X Zhong","year":"2019","unstructured":"Zhong X, Qian X, Chen G, Song X. The role of galectin-3 in heart failure and cardiovascular disease. Clin Exp Pharmacol Physiol. 2019;46(3):197\u2013203.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"14","key":"272_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","volume":"60","author":"JE Ho","year":"2012","unstructured":"Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol. 2012;60(14):1249\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"272_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ejhf.273","volume":"17","author":"RA de Boer","year":"2015","unstructured":"de Boer RA, Daniels LB, Maisel AS, Januzzi JL Jr. State of the art: newer biomarkers in heart failure. Eur J Heart Fail. 2015;17(6):559\u201369.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"272_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1373\/clinchem.2010.159277","volume":"57","author":"KB Shah","year":"2011","unstructured":"Shah KB, Kop WJ, Christenson RH, Diercks DB, Henderson S, Hanson K, et al. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction. Clin Chem. 2011;57(6):874\u201382.","journal-title":"Clin Chem"},{"key":"272_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2016.04.007","volume":"457","author":"M Beltrami","year":"2016","unstructured":"Beltrami M, Ruocco G, Dastidar AG, Franci B, Lucani B, Aloia E, et al. Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction. Clin Chim Acta. 2016;457:99\u2013105.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"272_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","volume":"12","author":"RV Shah","year":"2010","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail. 2010;12(8):826\u201332.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"272_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/joim.12723","volume":"283","author":"AI Nagy","year":"2018","unstructured":"Nagy AI, Hage C, Merkely B, Donal E, Daubert JC, Linde C, et al. Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction. J Intern Med. 2018;283(4):380\u201391.","journal-title":"J Intern Med"},{"issue":"1","key":"272_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14017431.2019.1583363","volume":"53","author":"E Najjar","year":"2019","unstructured":"Najjar E, Fax\u00e9n UL, Hage C, Donal E, Daubert JC, Linde C, et al. ST2 in heart failure with preserved and reduced ejection fraction. Scand Cardiovasc J. 2019;53(1):21\u20137.","journal-title":"Scand Cardiovasc J"},{"key":"272_CR30","doi-asserted-by":"crossref","unstructured":"Zile MR, Jhund PS, Baicu CF, Claggett BL, Pieske B, Voors AA, et al. Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction: Data from the prospective comparison of ARNI with ARB on management of heart failure with preserved ejection fraction study. Circ Heart Fail. 2016;9:e002551.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551"},{"issue":"4","key":"272_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/CIRCHEARTFAILURE.108.833707","volume":"2","author":"RV Shah","year":"2009","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail. 2009;2(4):311\u20139.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"272_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00380-015-0691-z","volume":"31","author":"BE Fenster","year":"2016","unstructured":"Fenster BE, Lasalvia L, Schroeder JD, Smyser J, Silveira LJ, Buckner JK, et al. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension. Heart Vessel. 2016;31(6):939\u201346.","journal-title":"Heart Vessel"},{"issue":"2","key":"272_CR33","doi-asserted-by":"publisher","first-page":"204589402091583","DOI":"10.1177\/2045894020915832","volume":"10","author":"RS Pratama","year":"2020","unstructured":"Pratama RS, Hartopo AB, Anggrahini DW, Dewanto VC, Dinarti LK. Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect. Pulm Circ. 2020;10(2):2045894020915832.","journal-title":"Pulm Circ"},{"issue":"10","key":"272_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/jcm8101517","volume":"8","author":"LW Geenen","year":"2019","unstructured":"Geenen LW, Baggen VJM, Kauling RM, Koudstaal T, Boomars KA, Boersma E, et al. The prognostic value of soluble ST2 in adults with pulmonary hypertension. J Clin Med. 2019;8(10):1517.","journal-title":"J Clin Med"},{"issue":"11","key":"272_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"272_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685\u2013713.","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"272_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"272_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303\u201371.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"272_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1 Pt 2","key":"272_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcmg.2019.12.004","volume":"13","author":"JK Oh","year":"2020","unstructured":"Oh JK, Miranda WR, Bird JG, Kane GC, Nagueh SF. The 2016 diastolic function guideline: is it already time to revisit or revise them? JACC Cardiovasc Imaging. 2020;13(1 Pt 2):327\u201335.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"272_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591\u2013600.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"272_CR42","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10741-019-09807-z","volume":"24","author":"M Sarhene","year":"2019","unstructured":"Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, et al. Biomarkers in heart failure: the past, current and future. Heart Fail Rev. 2019;24(6):867\u2013903.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"272_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3343\/alm.2016.36.6.542","volume":"36","author":"V Celic","year":"2016","unstructured":"Celic V, Majstorovic A, Pencic-Popovic B, Sljivic A, Lopez-Andres N, Roy I, et al. Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome. Ann Lab Med. 2016;36(6):542\u20139.","journal-title":"Ann Lab Med"},{"issue":"7","key":"272_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","volume":"50","author":"JL Januzzi Jr","year":"2007","unstructured":"Januzzi JL Jr, Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (pro-brain natriuretic peptide investigation of dyspnea in the emergency department) study. J Am Coll Cardiol. 2007;50(7):607\u201313.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"272_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.amjcard.2010.09.011","volume":"107","author":"S Manzano-Fern\u00e1ndez","year":"2011","unstructured":"Manzano-Fern\u00e1ndez S, Mueller T, Pascual-Figal D, Truong QA, Januzzi JL. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol. 2011;107(2):259\u201367.","journal-title":"Am J Cardiol"},{"issue":"6","key":"272_CR46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","volume":"30","author":"K Yanaba","year":"2011","unstructured":"Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol. 2011;30(6):825\u201330.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"272_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/07853890.2010.538080","volume":"43","author":"RA de Boer","year":"2011","unstructured":"de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med. 2011;43(1):60\u20138.","journal-title":"Ann Med"},{"issue":"3","key":"272_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3899\/jrheum.110755","volume":"39","author":"T Taniguchi","year":"2012","unstructured":"Taniguchi T, Asano Y, Akamata K, Noda S, Masui Y, Yamada D, et al. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis. J Rheumatol. 2012;39(3):539\u201344.","journal-title":"J Rheumatol"},{"key":"272_CR49","doi-asserted-by":"publisher","unstructured":"Mora GF, Zubieta MR. Galectin-1 and Galectin-3 expression in lesional skin of patients with systemic sclerosis-association with disease severity. J Clin Rheumatol. 2020 Jun 4. Doi: https:\/\/doi.org\/10.1097\/RHU.0000000000001367. Online ahead of print.","DOI":"10.1097\/RHU.0000000000001367"},{"key":"272_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2016.12.140","volume":"233","author":"R Faludi","year":"2017","unstructured":"Faludi R, Nagy G, T\u0151k\u00e9s-F\u00fczesi M, Kov\u00e1cs K, Czirj\u00e1k L, Kom\u00f3csi A. Galectin-3 is an independent predictor of survival in systemic sclerosis. Int J Cardiol. 2017;233:118\u201324.","journal-title":"Int J Cardiol"},{"issue":"1","key":"272_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.201509-1753OC","volume":"194","author":"JE Ho","year":"2016","unstructured":"Ho JE, Gao W, Levy D, Santhanakrishnan R, Araki T, Rosas IO, et al. Galectin-3 is associated with restrictive lung disease and interstitial lung abnormalities. Am J Respir Crit Care Med. 2016;194(1):77\u201383.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"272_CR52","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cardfail.2016.02.012","volume":"22","author":"M Cameli","year":"2016","unstructured":"Cameli M, Mondillo S, Righini FM, Lisi M, Dokollari A, Lindqvist P, et al. Left ventricular deformation and myocardial fibrosis in patients with advanced heart failure requiring transplantation. J Card Fail. 2016;22(11):901\u20137.","journal-title":"J Card Fail"},{"issue":"7","key":"272_CR53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ejechocard\/jer318","volume":"13","author":"M Saito","year":"2012","unstructured":"Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G, et al. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2012;13(7):617\u201323.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"272_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijcard.2017.08.072","volume":"249","author":"M Hrom\u00e1dka","year":"2017","unstructured":"Hrom\u00e1dka M, Seidlerov\u00e1 J, Such\u00fd D, Rajdl D, Lhotsk\u00fd J, Ludv\u00edk J, et al. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - relationship with biochemical and echocardiography parameters. Int J Cardiol. 2017;249:448\u201353.","journal-title":"Int J Cardiol"},{"issue":"3","key":"272_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","volume":"3","author":"SS Kuppahally","year":"2010","unstructured":"Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010;3(3):231\u20139.","journal-title":"Circ Cardiovasc Imaging."},{"issue":"5","key":"272_CR56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4070\/kcj.2012.42.5.311","volume":"42","author":"AY Her","year":"2012","unstructured":"Her AY, Choi EY, Shim CY, Song BW, Lee S, Ha JW, et al. Prediction of left atrial fibrosis with speckle tracking echocardiography in mitral valve disease: a comparative study with histopathology. Korean Circ J. 2012;42(5):311\u20138.","journal-title":"Korean Circ J"},{"issue":"5","key":"272_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jcmg.2014.12.026","volume":"8","author":"M Lisi","year":"2015","unstructured":"Lisi M, Cameli M, Righini FM, Malandrino A, Tacchini D, Focardi M, et al. RV longitudinal deformation correlates with myocardial fibrosis in patients with end-stage heart failure. JACC Cardiovasc Imaging. 2015;8(5):514\u201322.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"272_CR58","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1515\/cclm-2014-0278","volume":"52","author":"PA McCullough","year":"2014","unstructured":"McCullough PA. Practical experience using galectin-3 in heart failure. Clin Chem Lab Med. 2014;52(10):1425\u201331.","journal-title":"Clin Chem Lab Med"},{"issue":"21\u201322","key":"272_CR59","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.cca.2010.07.014","volume":"411","author":"J Lu","year":"2010","unstructured":"Lu J, Snider JV, Grenache DG. Establishment of reference intervals for soluble ST2 from a United States population. Clin Chim Acta. 2010;411(21\u201322):1825\u20136.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"272_CR60","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ejhf.1406","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the heart failure association (HFA) of the European Society of Cardiology. Eur J Heart Fail. 2019;21(3):272\u201385.","journal-title":"Eur J Heart Fail"}],"container-title":["Cardiovascular Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-022-00272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12947-022-00272-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-022-00272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T23:04:08Z","timestamp":1700089448000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiovascularultrasound.biomedcentral.com\/articles\/10.1186\/s12947-022-00272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1186\/s12947-022-00272-7","relation":{},"ISSN":["1476-7120"],"issn-type":[{"value":"1476-7120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki. The institutional ethics committee approved the study. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}